Enhancement of chemotherapeutically-induced apoptosis in vivo by biochemical modulation of poly (ADP-ribose) polymerase

Oncology Reports

Volumn 3, Issue 2, 1996, Pages 317-322

  Martin, D S ^a   Stolfi, R L ^a   Nord, L D ^a   Colofiore, J R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; ATP depletion; Biochemical modulation; Chemotherapy; Poly (ADP ribose) polymerase

Indexed keywords

1,5 DIHYDROXYISOQUINOLINE; 6 AMINONICOTINAMIDE; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; MELPHALAN; METHYLMERCAPTOPURINE RIBONUCLEOSIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SPARFOSIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029915244     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.3.2.317     Document Type: Article

References (1)

1. Corcoran GB, Fix L, Jones D, Moslen MT, Nicotera P, Oberhammer FA and Buttyan R: Apoptosis: Molecular control point in toxicity. Toxicol Appl Pharmacol 128: 169-181, 1994.